How to Capture Adverse Events in Electronic Case Report Forms (eCRFs)

Published on 22/12/2025

Step-by-Step Guide to Capturing Adverse Events in Electronic CRFs

Electronic Case Report Forms (eCRFs) are now standard in modern clinical trials for recording all study data, including adverse events (AEs). Proper AE documentation in eCRFs ensures regulatory compliance, supports safety signal detection, and maintains data integrity. This guide walks through best practices and essential steps for accurately capturing AEs using eCRFs in clinical research settings.

Table of Contents

Why eCRF-Based AE Documentation Matters:

Enhances accuracy and traceability
Ensures compliance with USFDA, EMA, and CDSCO guidelines
Enables automated coding and analysis
Improves efficiency in monitoring and data queries
Facilitates standardized safety reporting

Key Elements of an AE Entry in eCRF:

AE Term (verbatim description)
Start Date and End Date
Severity (per CTCAE guidelines)
Causality (Related / Not Related)
Seriousness (Yes / No)
Action Taken (e.g., Drug Withdrawn, Dose Reduced)
Outcome (e.g., Resolved, Ongoing, Fatal)
Is it an SAE?
Was it Reported to IRB?
Was it Reported to Sponsor?

Step-by-Step AE Capture Process in eCRF:

Step 1: Identify the AE

Adverse events may be discovered through patient self-reporting, lab results, physical exams, or clinician observations. Investigators are responsible for verifying and recording the AE.

Step 2: Access the AE Form in the eCRF System

the Electronic Data Capture (EDC) platform, such as Medidata Rave, Oracle InForm, or Veeva EDC, and navigate to the subject’s AE page.

Step 3: Enter AE Verbatim Term

Use the subject’s exact words or investigator diagnosis (e.g., “headache,” “nausea”). Avoid abbreviations. The term will be auto-coded using MedDRA during data management.

Step 4: Enter Onset and Resolution Dates

Ensure accurate dates. If the AE is ongoing at the time of entry, mark the end date as “Ongoing” or leave it blank as per system rules.

Step 5: Grade Severity

Use CTCAE v5.0 criteria to assign a grade from 1 (mild) to 5 (death). Refer to AE-specific grading tables.

Step 6: Assess Causality

The investigator must select whether the AE is “Related,” “Possibly Related,” or “Not Related” to the study drug. Justification should be recorded in source documents.

Step 7: Specify Seriousness

Check “Yes” if the AE meets criteria such as hospitalization, disability, life-threatening, or death. This triggers SAE workflows.

Step 8: Record Actions Taken

Was the study drug discontinued, paused, or unchanged? Record changes in dosage or therapy.

Step 9: Record Outcome

Choose from resolved, resolving, ongoing, fatal, or unknown. Update if follow-up information becomes available.

Refer to Pharma SOP templates for AE and SAE eCRF completion instructions aligned with GCP.

eCRF System Features That Enhance AE Reporting:

Auto-population of known subject data (e.g., study drug)
Mandatory field validation to avoid missing data
MedDRA auto-coding and dictionary updates
Electronic signatures for investigator authentication
Audit trail of data entry and modifications

Best Practices for AE Documentation in eCRFs:

Use clean, unambiguous language
Complete AE entry within 24–48 hours of discovery
Cross-check eCRF entries with source notes for consistency
Resolve queries raised by monitors or data managers promptly
Update ongoing AEs regularly until resolved

Platforms like StabilityStudies.in offer AE reconciliation and review logs to maintain eCRF accuracy.

Common Errors to Avoid:

Leaving mandatory fields blank
Entering incorrect dates (e.g., AE start date after resolution)
Inconsistency between severity and seriousness
Missing causality assessment
Duplicate AE entries for the same event

How Monitors Review AE Entries in eCRFs:

Clinical Research Associates (CRAs) verify AE entries against source documentation during on-site or remote monitoring. They ensure:

Correct verbatim terms are used
Dates and grades align with medical records
Investigator assessment is documented
SAE escalation workflows are followed

Integration with Pharmacovigilance Systems:

Serious AE data captured in eCRFs often flow into safety databases such as Argus or ArisGlobal. The integration ensures timely expedited reporting and signal detection across sites and studies.

Sample Workflow for AE Entry and Reconciliation:

Subject reports headache during visit
Investigator reviews and documents in source notes
Study coordinator enters AE in eCRF
Investigator reviews and signs AE form
CRA verifies entry and raises any queries
Final AE reviewed and locked after resolution

Checklist for Accurate AE Capture in eCRFs:

[ ] AE term entered verbatim
[ ] Start and end dates provided
[ ] CTCAE grade assigned
[ ] Causality assessed by investigator
[ ] Action taken and outcome recorded
[ ] SAE box checked if applicable
[ ] eSignature added by PI
[ ] Matched with source data

Conclusion:

Capturing adverse events accurately in electronic CRFs is vital for clinical trial safety oversight and regulatory compliance. By following structured workflows, training site teams, and using robust EDC systems, clinical sites can ensure that AE data are accurate, complete, and audit-ready. Every entry in an eCRF tells a part of the safety story—make sure it’s told right.